Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

ImmunoCAP ECP Update

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

We would like to update you with a recent brochure from Thermo Fisher Scientific on the ImmunoCAPTM ECP for quantifying eosinophil cationic protein (ECP).
ImmunoCAPTM ECP measures the level of ECP in serum. A high level of serum ECP indicates inflammation which is a risk factor for asthmatic patients. Measuring ECP in a serum sample is an objec­tive and direct way of estimating the severity of airway inflammation and following the course of disease in asth­matic patients.
 
Clinical importance in asthma
 
ImmunoCAPTM ECP serum measurements can be used:

  • To monitor inflammation in asthma
  • To guide corticosteroid treatment in asthma
  • To find non-compliant patients

ImmunoCAPTM ECP helps to identify ongoing inflammation associated with asthma and aids in determining appropriate therapy for asthmatic patients.

Find out more about ImmunoCAP ECP

View Brochure >

View the 2024 Product Catalogue

Download Now >

Contact us for a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

IBL International – Proinsulin Intact ELISA.*

Unlock the future of diabetes detection with Proinsulin Intact ELISA for early and accurate diagnosis. Proinsulin, primarily produced in pancreatic β-cells, undergoes processing into insulin and…

Read full article

Clinical Utility of ImmunoCAP Tryptase

ImmunoCAP Tryptase is a well-known clinical marker in explaining severe reactions cause by insect venoms, drugs, or in systemic mastocytosis. (more…)

Read full article

Biosynex – Risankizumab

i-Tracker Risankizumab (Biosynex) is an automated assay intended for the quantitative measurement of Risankizumab (anti-IL23 agent) in human serum or plasma samples. (more…)

Read full article